Personalis, Inc. Common Stock (PSNL)
SERVICES-MEDICAL LABORATORIES
- Headquarters
- United States
- Employees
- 260
- Market Cap
- $1.5B
About Personalis, Inc. Common Stock
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
SentiSense also tracks daily options readings for Personalis, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Personalis, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.